Mitochondria are related to synaptic pathology in Alzheimer's disease

Stavros J Baloyannis1

  • 1Department of Neurology, School of Medicine, Aristotle University of Thessaloniki, 54006 Thessaloniki, Greece.

Insights

Mitochondrial changes in Alzheimer's disease neurons are linked to synaptic damage, not amyloid plaques. These alterations, including shape and size modifications, are prominent when the Golgi apparatus fragments.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Pathology

Background:

  • Mitochondrial morphology is implicated in Alzheimer's disease (AD) pathogenesis.
  • Mitochondrial dysfunction is associated with oxidative stress and Aβ-peptide toxicity in AD.

Purpose of the Study:

  • To investigate and quantify mitochondrial morphological and morphometric changes in neurons from various brain regions of Alzheimer's disease autopsy specimens.

Main Methods:

  • Electron microscopy was used for morphological assessment.
  • Autopsy specimens from Alzheimer's disease patients were analyzed.
  • Morphometric analysis quantified mitochondrial size, shape, and cristae structure.

Main Results:

  • Significant mitochondrial morphological and morphometric alterations were observed in multiple brain regions, including the hippocampus, neocortex, and thalamus.
  • These changes included altered cristae, osmiophilic material accumulation, and modifications in mitochondrial shape and size.
  • Mitochondrial alterations correlated with dendritic spine depletion and loss of dendritic branches, and were associated with synaptic pathology.
  • No direct relationship was found between mitochondrial alterations and amyloid deposit accumulation; however, they were prominent when Golgi apparatus fragmentation was present.

Conclusions:

  • Mitochondrial morphological and morphometric changes are a significant feature in Alzheimer's disease neurons across various brain regions.
  • These mitochondrial alterations are linked to neuronal structural damage, including dendritic pathology and synaptic dysfunction, rather than directly to amyloid deposition.
  • The findings suggest mitochondrial health is critical in Alzheimer's disease and may be influenced by Golgi apparatus integrity.

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...